Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWITCH ON booster immunogenicity study in healthcare workers
NL-OMON53985Completed
- Sponsor
- Erasmus MC
- Start
- Sep 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by Erasmus MC. Primary endpoints: Increase in antibody levels after booster, Rapid secondary recall response and 1 more. Started Sep 2022; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON53985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53985.